So because happy says there is no longer a DCVax platform, you take that to be the facts?
L for GBM is the base, and an extensive oncology treatment platform will be built off that.
No I can make up my own mind.
I am very disappointed Direct is not initiated all this time. Im convinced with solid biotech + business experience and schooling at the highest level NWBO already would have delivered the platform contributing a big puzzle to the cancer cure puzzle. But ales it had to be business ex-lawyers. And yes ex-lawyers if you dont practice law on a weekly basis.
Name one about 20-year-old biotech startup with only one drug being tested in one trial for one condition. There arent any.
On the other side if they pull L off its an incredible achievement given NWBO's management non biotech background.